Answers are grounded in this paper and cite their sources.
Reveals elevated malondialdehyde and depleted antioxidant capacity in coronary artery disease, highlighting an association with oxidative lipid damage.
Oxidative stress has been implicated in coronary artery disease (CAD). Malondialdehyde (MDA) is lipid end product. Bilirubin may act as an antioxidant that suppresses lipid oxidation. The role MDA and antioxidant capacity and their inter-relationship in patients with and without CAD was . Thirty-eight consecutive patients with angiographically diagnosed CAD were compared 60 age, and sex-matched controls. The controls had completely normal coronary arteries in . Plasma MDA, serum bilirubin, total homocysteine and total antioxidant capacity (TAC) were measured. Risk factors of CAD were determined for all subjects using National Cholesterol Program (NCEP)-Adult Treatment Panel (ATP)-III criteria. Serum MDA and total homocysteine were significantly higher, but TAC, total bilirubin and direct bilirubin levels were lower in patients when compared to the controls. Age, and sex-adjusted plasma MDA levels had negative with TAC (r = -0.30, p = 0.001) and total bilirubin (r = -0.30, p = 0.002) concentrations. In analysis by the multiple logistic regression method, serum MDA was significantly with CAD (OR = 1.15, 95% CI, 1.25 to 1.82; p < 0.0001)) after adjustment for lipid status and traditional risk factors in this study population. Increased serum MDA concentration, as biomarker of lipid peroxidation, low serum bilirubin and antioxidant capacity were observed in with angiographically defined CAD. The significant inverse correlation of the serum bilirubin MDA levels demands further in-depth investigations to clarify the association between them in the of CAD.
No takes yet. Share an insight, caveat, or question.
Ali Movahed (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: